We’re trimming a stock into strength, raising our price target
We are selling 50 shares of Cardinal Health at roughly $235. Following the trade, Jim Cramer’s Charitable Trust…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
Novo Nordisk is launching its weight loss pill Wegovy in the United Arab Emirates, the Danish drugmaker said…
Jim Cramer says to buy these two stocks — including one with nearly 20% upside
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
Eli Lilly makes a new push into vaccines – here’s what to know
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
Eli Lilly lawsuit says rebate fraud tied to Pentecostal church leaders
Eli Lilly says it has uncovered a long-running scheme to steal more than $200 million in rebates from…
Stocks making the biggest moves premarket: RACE, LEA, LUNR, MU
Check out some of the companies making headlines before the stock market’s opening bell: Autozone — The automotive…
Want to hop off the AI trade? Goldman says buy these stocks that have nothing to do with it
It may feel like the artificial intelligence trade is sucking all the oxygen out of the stock market…
Eli Lilly weight loss drug retatrutide clears obesity trial
Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering…
New data boosts our confidence in Lilly’s obesity pill. Plus, Google’s new AI
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…